Rhabdomyolysis is a serious condition characterized by the breakdown of skeletal muscle fibers, releasing their contents into the bloodstream. While various factors can cause rhabdomyolysis, including trauma and intense exercise, drug-induced rhabdomyolysis is a significant concern. Identifying and avoiding certain medications is crucial for preventing severe complications, particularly acute kidney injury (AKI).
Drug Classes to Avoid or Exercise Caution With
Statins (HMG-CoA Reductase Inhibitors)
Statins are commonly associated with rhabdomyolysis, although the risk is generally low, especially with modern statins at moderate doses. They can cause muscle damage by affecting mitochondrial function. The risk is dose-dependent and increases with certain drug combinations. Lipophilic statins, such as simvastatin and atorvastatin, may carry a higher risk than hydrophilic ones like pravastatin.
Fibrates
Fibrates, used to lower triglycerides, can increase the risk of rhabdomyolysis, particularly when taken with statins. Gemfibrozil is especially known for this interaction and is generally not recommended with statins.
Antibiotics
Some antibiotics are linked to an increased risk of rhabdomyolysis through direct toxicity or interactions. Daptomycin requires monitoring of creatine kinase (CK) levels. Macrolide antibiotics (erythromycin, clarithromycin) can inhibit the metabolism of statins, increasing their levels and the risk of rhabdomyolysis. Fluoroquinolones and certain other antibiotics have also been associated with the condition.
Antipsychotics and Antidepressants
These medications can induce rhabdomyolysis, sometimes through conditions like neuroleptic malignant syndrome (NMS). Atypical and typical antipsychotics, as well as various antidepressants, have been implicated in case reports.
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
While not directly toxic to muscles, NSAIDs are discouraged in rhabdomyolysis because they can worsen AKI by reducing kidney blood flow. Acetaminophen is a safer alternative for pain.
Recreational Drugs and Alcohol
Substances of abuse are a major cause of drug-induced rhabdomyolysis. Stimulants like cocaine and amphetamines can cause muscle breakdown through hyperthermia and increased activity. Opiates can lead to local muscle damage, while overdose can cause crush injuries from immobility. Alcohol abuse is directly myotoxic and can cause electrolyte imbalances.
High-Risk Drug-Drug Interactions
Interactions that increase the concentration of myotoxic drugs significantly raise the risk of rhabdomyolysis. Combining statins with fibrates, especially gemfibrozil, is a high-risk interaction. Statins metabolized by CYP3A4 (simvastatin, atorvastatin, lovastatin) can reach toxic levels when combined with CYP3A4 inhibitors like macrolide antibiotics, cyclosporine, or grapefruit juice. Combining statins with daptomycin also increases risk.
Conclusion
Several drugs and drug interactions can increase the risk of rhabdomyolysis, including statins, fibrates, and certain antibiotics. Patients must inform healthcare providers about all medications, supplements, and recreational drugs to identify potential risks. Holding or adjusting these medications under medical supervision is a key strategy to manage and prevent drug-induced rhabdomyolysis and its complications, particularly kidney damage. For detailed clinical information, consult {Link: NIH https://www.ncbi.nlm.nih.gov/books/NBK448168/}.